Human immunodeficiency virus (HIV) attacks cells that help the body fight infection, making a person more vulnerable to other infections and diseases. It is spread through contact with the bodily fluids of an HIV-positive person, such as through sex or sharing injection drug equipment. If left untreated, HIV can lead to acquired immunodeficiency syndrome (AIDS), the late stage of HIV infection that occurs when the body’s immune system is badly damaged because of the virus. There is no effective cure for HIV, but with proper medical care, it can be controlled.
State of the HIV/AIDS Epidemic in 2019
Article Drug Resistance and PrEP Breakthrough Infections Threaten Goals to End the HIV/AIDS Epidemic
HIV positive individuals who go undiagnosed or untreated, resistance to antiretroviral drugs and breakthrough infections in those taking pre-exposure prophylaxis (PrEP) are complicating the path to achieving the UNAIDS 95:95:95 goal.
Microbial Minutes: How a Second Person Was Cured of HIV
HIV/AIDS on ASM Podcasts
July 14, 2020
Virology Nobel Prizes, awards for research on tumor viruses, bacteriophages, virus structure, reverse transcriptase, hepatitis B virus, HIV-1 and human papillomaviruses.
Feb. 21, 2019
Dan Barouch lays out the unique challenges of HIV vaccine development and discusses the ongoing clinical trial with a vaccine developed in his lab.
Progress Toward 90-90-90 UNAIDS Goals
Global Progress as of 2019 and U.S. Progress as of 2016, Respectively
Sept. 5, 2019 Infant Model of HIV Opens New Avenues for Research
Researchers have developed an animal model to test HIV infection and therapies in infants, allowing them to develop biomarkers to predict viral rebound after antiretroviral therapy (ART) interruption. The simian-human immunodeficiency virus (SHIV)-infected infant rhesus macaque model, a collaborative effort among researchers at several institutions, is described in a recent issue of the journal mBio.